SGA
SNDX icon

Sector Gamma AS’s Syndax Pharmaceuticals SNDX Stock Holding History

Sector Gamma AS’s Portfolio SNDX Stock Details SNDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.28M Sell
241,739
-44,268
-15% -$921K 1.15% 30
2026
Q1 		$6.68M Buy
286,007
+33,945
+13% +$738K 1.58% 22
2025
Q4 		$5.3M Buy
252,062
+41,248
+20% +$720K 1.21% 28
2025
Q3 		$3.24M Buy
+210,814
New +$2.76M 0.8% 37

Other funds holding SNDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
EP
Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return

Sector Gamma AS's SNDX Position: Q2 2026 in Review

Sector Gamma AS reduced its Syndax Pharmaceuticals (SNDX) stake by 15% in Q2 2026, selling an estimated $921K and leaving 241,739 shares worth $5.28M. The position accounts for 1.15% of the portfolio, ranked #30.

Sector Gamma AS first reported a position in SNDX in Q3 2025 and has held it in 4 quarters since. The position peaked at $6.68M in Q1 2026. 243 funds tracked by Wall St. Rank hold SNDX as of Q2 2026.

  • Sector Gamma AS held 241,739 shares of Syndax Pharmaceuticals worth $5.28M as of Q2 2026.
  • Sector Gamma AS sold 44,268 Syndax Pharmaceuticals shares in Q2 2026, an estimated $921K.
  • Syndax Pharmaceuticals made up 1.15% of Sector Gamma AS's portfolio in Q2 2026, its #30 holding.
  • Sector Gamma AS first reported a position in Syndax Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
  • Sector Gamma AS's Syndax Pharmaceuticals position peaked at $6.68M in Q1 2026.
  • 243 funds tracked by Wall St. Rank held Syndax Pharmaceuticals as of Q2 2026.

Based on Sector Gamma AS's 13F filing for Q2 2026, filed 12 Aug 2026.